Johnson & Johnson proposes $5.5 billion talc settlement to end marathon legal fight
Summary
Johnson & Johnson has agreed to pay $5.5 billion to settle most of the remaining lawsuits claiming its talc products caused ovarian cancer. The company will make an initial payment of up to $3 billion next year, with no further payments due until 2028, and this settlement depends on 95% of claimants accepting the offer.Key Facts
- Johnson & Johnson faces lawsuits claiming its talc products caused ovarian cancer.
- The company has been fighting these lawsuits for over ten years.
- A previous $9 billion settlement proposed by a Johnson & Johnson subsidiary was rejected by a bankruptcy judge.
- Johnson & Johnson decided not to appeal the rejection and continued to fight in court.
- A federal judge recently challenged plaintiffs to show direct proof that the talc caused cancer, which has been difficult.
- The new proposed settlement requires at least 95% of remaining claimants to participate.
- Johnson & Johnson will pay up to $3 billion in 2025, with no payments required until 2028.
- The company has already settled about 95% of related lawsuits involving other claims and disputes.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
